Veeva Systems (VEEV) Becomes Default Clinical Software Across A Major Research Partner

Veeva Systems (NYSE:VEEV) said IQVIA will adopt Veeva's core clinical applications as enterprise standards across all IQVIA studies. The expanded agreement covers Veeva Clinical Trial Management System, eTMF, Study Startup, and Site Connect for IQVIA's global research operations. The move deepens Veeva's role in IQVIA's clinical execution workflow and broadens its reach across contract research and biopharma customers. IQVIA's decision to standardize on Veeva's clinical suite reshapes how...